Similarly, CD103–CD8+ Trm cells accumulated in the guts of patients with inflammatory bowel disease (IBD), and the rebalancing of CD103–CD8+ and CD103+CD8+ Trm cells was associated with disease remission56, suggesting CD103– cells promote disease pathogenesis. This evidence concerns the gene CD8A and inflammatory bowel disease.